A detailed history of American Capital Management Inc transactions in Illumina, Inc. stock. As of the latest transaction made, American Capital Management Inc holds 69,849 shares of ILMN stock, worth $7.53 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
69,849
Previous 75,520 7.51%
Holding current value
$7.53 Million
Previous $10.5 Million 8.79%
% of portfolio
0.31%
Previous 0.36%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$127.73 - $147.2 $724,356 - $834,771
-5,671 Reduced 7.51%
69,849 $9.59 Million
Q4 2023

Feb 14, 2024

SELL
$92.79 - $142.53 $9.62 Million - $14.8 Million
-103,697 Reduced 57.86%
75,520 $10.5 Million
Q3 2023

Nov 14, 2023

SELL
$128.91 - $192.44 $1.62 Million - $2.42 Million
-12,554 Reduced 6.55%
179,217 $24.6 Million
Q2 2023

Aug 14, 2023

SELL
$183.43 - $232.67 $6.64 Million - $8.42 Million
-36,177 Reduced 15.87%
191,771 $36 Million
Q1 2023

May 03, 2023

SELL
$193.75 - $232.55 $293,337 - $352,080
-1,514 Reduced 0.66%
227,948 $53 Million
Q4 2022

Feb 14, 2023

SELL
$187.24 - $242.74 $149,043 - $193,221
-796 Reduced 0.35%
229,462 $46.4 Million
Q3 2022

Nov 14, 2022

SELL
$177.23 - $227.44 $165,355 - $212,201
-933 Reduced 0.4%
230,258 $43.9 Million
Q2 2022

Aug 15, 2022

SELL
$181.58 - $368.0 $2.36 Million - $4.78 Million
-12,976 Reduced 5.31%
231,191 $42.6 Million
Q1 2022

May 16, 2022

BUY
$303.87 - $423.8 $773,349 - $1.08 Million
2,545 Added 1.05%
244,167 $85.3 Million
Q4 2021

Feb 14, 2022

BUY
$347.28 - $421.83 $516,058 - $626,839
1,486 Added 0.62%
241,622 $91.9 Million
Q3 2021

Nov 15, 2021

SELL
$405.61 - $524.84 $2.98 Million - $3.85 Million
-7,337 Reduced 2.96%
240,136 $97.4 Million
Q2 2021

Aug 13, 2021

BUY
$372.84 - $481.5 $657,689 - $849,366
1,764 Added 0.72%
247,473 $117 Million
Q1 2021

May 17, 2021

BUY
$361.28 - $504.76 $567,570 - $792,977
1,571 Added 0.64%
245,709 $94.4 Million
Q4 2020

Feb 16, 2021

BUY
$292.7 - $370.96 $240,014 - $304,187
820 Added 0.34%
244,138 $90.3 Million
Q3 2020

Nov 16, 2020

SELL
$268.51 - $400.74 $3.32 Million - $4.95 Million
-12,346 Reduced 4.83%
243,318 $75.2 Million
Q2 2020

Aug 13, 2020

SELL
$256.46 - $373.01 $711,420 - $1.03 Million
-2,774 Reduced 1.07%
255,664 $94.7 Million
Q1 2020

May 15, 2020

BUY
$209.2 - $335.53 $233,048 - $373,780
1,114 Added 0.43%
258,438 $70.6 Million
Q4 2019

Feb 12, 2020

BUY
$288.29 - $335.49 $410,524 - $477,737
1,424 Added 0.56%
257,324 $85.4 Million
Q3 2019

Nov 14, 2019

SELL
$266.84 - $378.23 $241,490 - $342,298
-905 Reduced 0.35%
255,900 $77.9 Million
Q2 2019

Nov 14, 2019

BUY
$300.59 - $368.15 $293,075 - $358,946
975 Added 0.38%
256,805 $94.5 Million
Q2 2019

Aug 12, 2019

SELL
$300.59 - $368.15 $159,312 - $195,119
-530 Reduced 0.21%
255,830 $94.2 Million
Q1 2019

May 14, 2019

BUY
$272.57 - $321.18 $255,398 - $300,945
937 Added 0.37%
256,360 $79.6 Million
Q4 2018

Feb 08, 2019

BUY
$272.46 - $366.54 $929,633 - $1.25 Million
3,412 Added 1.35%
255,423 $76.6 Million
Q3 2018

Nov 02, 2018

SELL
$279.04 - $367.06 $276,807 - $364,123
-992 Reduced 0.39%
252,011 $92.5 Million
Q2 2018

Jul 17, 2018

SELL
$228.17 - $292.07 $326,739 - $418,244
-1,432 Reduced 0.56%
253,003 $70.7 Million
Q1 2018

Apr 23, 2018

SELL
$209.54 - $253.91 $1.04 Million - $1.26 Million
-4,960 Reduced 1.91%
254,435 $60.2 Million
Q4 2017

Jan 23, 2018

BUY
$202.23 - $230.03 $2.36 Million - $2.69 Million
11,685 Added 4.72%
259,395 $56.7 Million
Q3 2017

Apr 05, 2018

BUY
$172.3 - $213.93 $4,307 - $5,348
25 Added 0.01%
247,710 $49.3 Million
Q3 2017

Oct 20, 2017

SELL
$172.3 - $213.93 $1.45 Million - $1.8 Million
-8,430 Reduced 3.29%
247,685 $49.3 Million
Q2 2017

Apr 19, 2018

BUY
N/A
9,665 Added 3.92%
256,115 $44.4 Million
Q1 2017

Apr 18, 2018

BUY
N/A
246,450
246,450 $42.1 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $17B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track American Capital Management Inc Portfolio

Follow American Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Capital Management Inc with notifications on news.